Cellectis
CLLS
#9392
Rank
โ‚น14.76 B
Marketcap
โ‚น146.55
Share price
4.79%
Change (1 day)
-54.67%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น14.76 Billion

As of September 2026 Cellectis has a market cap of โ‚น14.76 Billion. This makes Cellectis the world's 9392th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น14.76 B-65.5%
2025โ‚น42.77 B246.68%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Sep 20th, 2026 the market cap of Cellectis was reported to be:

โ‚น14.73 Billion
by Nasdaq info icon info icon
โ‚น14.76 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น7.738 T 52,324.06%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚น292.35 B 1,880.61%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น159.73 B 982.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น43.95 B 197.81%๐Ÿ‡บ๐Ÿ‡ธ USA